{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:25:10Z","timestamp":1790742310877,"version":"4.1.0"},"reference-count":69,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:sec id=\"ab-doi220066-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Keloids and hypertrophic scars (excessive scarring) are relatively understudied disfiguring chronic skin conditions with high treatment resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate established comorbidities of excessive scarring in European individuals, with comparisons across ethnic groups, and to identify novel comorbidities via a phenome-wide association study (PheWAS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This multicenter cross-sectional population-based cohort study used UK Biobank (UKB) data and fitted logistic regression models for testing associations between excessive scarring and a variety of outcomes, including previously studied comorbidities and 1518 systematically defined disease categories. Additional modeling was performed within subgroups of participants defined by self-reported ethnicity (as defined in UK Biobank). Of 502\u202f701 UKB participants, analyses were restricted to 230078 individuals with linked primary care records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Keloid or hypertrophic scar diagnoses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Previously studied disease associations (hypertension, uterine leiomyoma, vitamin D deficiency, atopic eczema) and phenotypes defined in the PheWAS Catalog.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 972 people with excessive scarring, there was a higher proportion of female participants compared with the 229\u202f106 controls (65% vs 55%) and a lower proportion of White ethnicity (86% vs 95%); mean (SD) age of the total cohort was 64 (8) years. Associations were identified with hypertension and atopic eczema in models accounting for age, sex, and ethnicity, and the association with atopic eczema (odds ratio [OR], 1.68; 95% CI, 1.36-2.07;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) remained statistically significant after accounting for additional potential confounders. Fully adjusted analyses within ethnic groups revealed associations with hypertension in Black participants (OR, 2.05; 95% CI, 1.13-3.72;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02) and with vitamin D deficiency in Asian participants (OR, 2.24; 95% CI, 1.26-3.97;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.006). The association with uterine leiomyoma was borderline significant in Black women (OR, 1.93; 95% CI, 1.00-3.71;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.05), whereas the association with atopic eczema was significant in White participants (OR, 1.68; 95% CI, 1.34-2.12;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and showed a similar trend in Asian (OR, 2.17; 95% CI, 1.01-4.67;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.048) and Black participants (OR, 1.89; 95% CI, 0.83-4.28;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.13). The PheWAS identified 110 significant associations across disease systems; of the nondermatological, musculoskeletal disease and pain symptoms were prominent.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi220066-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cross-sectional study validated comorbidities of excessive scarring in UKB with comprehensive coverage of health outcomes. It also documented additional phenome-wide associations that will serve as a reference for future studies to investigate common underlying pathophysiologic mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2022.5607","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:00:53Z","timestamp":1672830053000},"page":"172","source":"Crossref","is-referenced-by-count":66,"title":["Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank"],"prefix":"10.1001","volume":"159","author":[{"given":"Chuin Y.","family":"Ung","sequence":"first","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic and Medical Biosciences, King\u2019s College London, London, United Kingdom"},{"name":"Centre for Inflammation Biology & Cancer Immunology, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair","family":"Warwick","sequence":"additional","affiliation":[{"name":"University College London Institute of Cardiovascular Science, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Onoufriadis","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic and Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Barker","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic and Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddy","family":"Parsons","sequence":"additional","affiliation":[{"name":"Randall Division of Cell and Molecular Biophysics, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, School of Basic and Medical Biosciences, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya J.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Biology & Cancer Immunology, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Dand","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics, School of Basic & Medical Biosciences, Faculty of Life Sciences & Medicine, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi220066r1","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/exd.v30.1","article-title":"Keloid disorder: fibroblast differentiation and gene expression profile in fibrotic skin diseases.","volume":"30","author":"Macarak","year":"2021","journal-title":"Exp Dermatol"},{"issue":"1","key":"doi220066r2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.jid.5700604","article-title":"IL-6 signaling pathway in keloids: a target for pharmacologic intervention?","volume":"127","author":"Uitto","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi220066r3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1006\/excr.1993.1302","article-title":"Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor.","volume":"209","author":"Tan","year":"1993","journal-title":"Exp Cell Res"},{"issue":"1","key":"doi220066r4","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/exd.v30.1","article-title":"Hypertrophic scars and keloids: overview of the evidence and practical guide for differentiating between these abnormal scars.","volume":"30","author":"Limandjaja","year":"2021","journal-title":"Exp Dermatol"},{"issue":"3","key":"doi220066r5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jid.2019.10.002","article-title":"Clinical challenge and call for research on keloid disorder: meeting report from the 3rd International Keloid Research Foundation Symposium, Beijing 2019.","volume":"140","author":"Uitto","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"10","key":"doi220066r6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00403-006-0651-7","article-title":"Quality of life of patients with keloid and hypertrophic scarring.","volume":"297","author":"Bock","year":"2006","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"doi220066r7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40257-016-0175-7","article-title":"Keloids and hypertrophic scars: a spectrum of clinical challenges.","volume":"17","author":"Trace","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"doi220066r8","first-page":"550","article-title":"Update on the treatment of scars.","volume":"18","author":"Gonz\u00e1lez","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"doi220066r9","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3389\/fphys.2020.01009","article-title":"Comorbidity networks in cardiovascular diseases.","volume":"11","author":"Cruz-\u00c1vila","year":"2020","journal-title":"Front Physiol"},{"issue":"1","key":"doi220066r10","doi-asserted-by":"publisher","first-page":"9390","DOI":"10.1038\/s41598-021-88789-1","article-title":"Risk of cancer development in patients with keloids.","volume":"11","author":"Lu","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"doi220066r11","doi-asserted-by":"publisher","first-page":"23669","DOI":"10.1038\/s41598-021-03164-4","article-title":"The increased prevalence of keloids in atopic dermatitis patients with allergic comorbidities: a nationwide retrospective cohort study.","volume":"11","author":"Kwon","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"doi220066r12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022865","article-title":"Keloid risk in patients with atopic dermatitis: a nationwide retrospective cohort study in Taiwan.","volume":"8","author":"Lu","year":"2018","journal-title":"BMJ Open"},{"issue":"9","key":"doi220066r13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00403-014-1491-5","article-title":"Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: a nationwide population-based study.","volume":"306","author":"Sun","year":"2014","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"doi220066r14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/wrr.v29.3","article-title":"Does vitamin D deficiency predispose to keloids via dysregulation of koebnerisin (S100A15)? a case-control study.","volume":"29","author":"El Hadidi","year":"2021","journal-title":"Wound Repair Regen"},{"issue":"1","key":"doi220066r15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000350121","article-title":"The TaqI gene polymorphisms of VDR and the circulating 1,25-dihydroxyvitamin D levels confer the risk for the keloid scarring in Chinese cohorts.","volume":"32","author":"Yu","year":"2013","journal-title":"Cell Physiol Biochem"},{"issue":"9","key":"doi220066r16","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1111\/ijd.2017.56.issue-9","article-title":"A case-control study analyzing the association of keloids with hypertension and obesity.","volume":"56","author":"Rutherford","year":"2017","journal-title":"Int J Dermatol"},{"issue":"12","key":"doi220066r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084737","article-title":"Keloids and ultrasound detected fibroids in young African American women.","volume":"8","author":"Harmon","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"doi220066r18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"23","key":"doi220066r19","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association.","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"doi220066r20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175508","article-title":"Evaluating phecodes, clinical classification software, and ICD-9-CM codes for phenome-wide association studies in the electronic health record.","volume":"12","author":"Wei","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"doi220066r21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R.","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"issue":"10","key":"doi220066r22","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review.","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"issue":"2","key":"doi220066r23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/jech-2019-213364","article-title":"Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis.","volume":"75","author":"Qin","year":"2021","journal-title":"J Epidemiol Community Health"},{"issue":"7","key":"doi220066r24","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"doi220066r25","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3945\/ajcn.113.076430","article-title":"Prediction of vitamin D deficiency by simple patient characteristics.","volume":"99","author":"Sohl","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"doi220066r26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors.","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"doi220066r27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package.","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"issue":"43","key":"doi220066r28","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss","article-title":"Welcome to the tidyverse.","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"issue":"16","key":"doi220066r30","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/bioinformatics\/btu197","article-title":"R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment.","volume":"30","author":"Carroll","year":"2014","journal-title":"Bioinformatics"},{"issue":"57","key":"doi220066r31","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.21105\/joss","article-title":"The targets r package: a dynamic make-like function-oriented pipeline toolkit for reproducibility and high-performance computing.","volume":"6","author":"Landau","year":"2021","journal-title":"J Open Source Softw"},{"issue":"1","key":"doi220066r34","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1111\/ijd.12969","article-title":"Association of keloids with systemic medical conditions: a retrospective analysis.","volume":"55","author":"Adotama","year":"2016","journal-title":"Int J Dermatol"},{"issue":"8999","key":"doi220066r35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0140-6736(96)90042-2","article-title":"Keloid associated with hypertension.","volume":"347","author":"Snyder","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"doi220066r36","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.pcad.2016.09.004","article-title":"Hypertension treatment in Blacks: discussion of the US clinical practice guidelines.","volume":"59","author":"Williams","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"doi220066r37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and risk factors of uterine fibroids.","volume":"46","author":"Pavone","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"6, pt 1","key":"doi220066r38","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.HYP.26.6.858","article-title":"Does keloid pathogenesis hold the key to understanding Black\/White differences in hypertension severity?","volume":"26","author":"Dustan","year":"1995","journal-title":"Hypertension"},{"key":"doi220066r39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.597741","article-title":"RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17\/Th22, and JAK3-skewing.","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"doi220066r40","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/2000656X.2019.1612752","article-title":"Periostin is induced by IL-4\/IL-13 in dermal fibroblasts and promotes RhoA\/ROCK pathway-mediated TGF-\u00df1 secretion in abnormal scar formation.","volume":"53","author":"Maeda","year":"2019","journal-title":"J Plast Surg Hand Surg"},{"issue":"2","key":"doi220066r41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","article-title":"The IL-4\/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.","volume":"312","author":"Nguyen","year":"2020","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"doi220066r42","first-page":"988","article-title":"Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts.","volume":"292","author":"Oriente","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"doi220066r43","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1111\/jdv.v34.4","article-title":"Keloid lesions show increased IL-4\/IL-13 signaling and respond to Th2-targeting dupilumab therapy.","volume":"34","author":"Diaz","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi220066r44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jdcr.2021.04.034","article-title":"Dupilumab as an adjuvant treatment for keloid-associated symptoms.","volume":"13","author":"Wong","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"e2","key":"doi220066r45","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1136\/amiajnl-2013-001861","article-title":"Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications.","volume":"20","author":"Warner","year":"2013","journal-title":"J Am Med Inform Assoc"},{"issue":"5","key":"doi220066r46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jcpe.12086","article-title":"Discovering medical conditions associated with periodontitis using linked electronic health records.","volume":"40","author":"Boland","year":"2013","journal-title":"J Clin Periodontol"},{"issue":"3","key":"doi220066r47","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/art.37801","article-title":"Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls.","volume":"65","author":"Liao","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"doi220066r48","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000864","article-title":"Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity.","volume":"7","author":"Zhang","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"doi220066r49","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00006534-197510000-00019","article-title":"Presumptive evidence of the effect of pregnancy estrogens on keloid growth: case report.","volume":"56","author":"Moustafa","year":"1975","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"doi220066r50","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12154","article-title":"Adverse effects of pregnancy on keloids and hypertrophic scars.","volume":"12","author":"Ibrahim","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"doi220066r51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s13555-019-00327-0","article-title":"Sex differences in keloidogenesis: an analysis of 1659 keloid patients in Japan.","volume":"9","author":"Noishiki","year":"2019","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"doi220066r52","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1054\/mehy.2001.1426","article-title":"Keloids\u2014the sebum hypothesis revisited.","volume":"58","author":"Fong","year":"2002","journal-title":"Med Hypotheses"},{"key":"doi220066r53","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fcell.2020.00360","article-title":"The keloid disorder: heterogeneity, histopathology, mechanisms and models.","volume":"8","author":"Limandjaja","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"doi220066r54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0007-1226(79)90037-7","article-title":"Does an immune reaction to sebum in wounds cause keloid scars? beneficial effect of desensitisation.","volume":"32","author":"Yagi","year":"1979","journal-title":"Br J Plast Surg"},{"issue":"3","key":"doi220066r55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/sj.jid.5701107","article-title":"Human skin keloid fibroblasts display bioenergetics of cancer cells.","volume":"128","author":"Vincent","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"12","key":"doi220066r56","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.jid.2018.05.017","article-title":"Time series integrative analysis of RNA sequencing and microRNA expression data reveals key biologic wound healing pathways in keloid-prone individuals.","volume":"138","author":"Onoufriadis","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"doi220066r57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","article-title":"The role of TGF-\u00df\/SMAD4 signaling in cancer.","volume":"14","author":"Zhao","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"1","key":"doi220066r58","doi-asserted-by":"publisher","first-page":"32231","DOI":"10.1038\/srep32231","article-title":"TGF-\u00df1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21.","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"doi220066r59","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2133.2009.09511.x","article-title":"Mechanisms of transforming growth factor beta(1)\/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.","volume":"162","author":"He","year":"2010","journal-title":"Br J Dermatol"},{"issue":"20","key":"doi220066r60","doi-asserted-by":"publisher","first-page":"7697","DOI":"10.3390\/ijms21207697","article-title":"The Wnt signalling pathway: a tailored target in cancer.","volume":"21","author":"Koni","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"doi220066r61","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/DAD.0000000000001661","article-title":"Wnt signaling pathway proteins in scar, hypertrophic scar, and keloid: evidence for a continuum?","volume":"42","author":"Chaudet","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"doi220066r62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tcb.2014.10.001","article-title":"Understanding fibroblast heterogeneity in the skin.","volume":"25","author":"Driskell","year":"2015","journal-title":"Trends Cell Biol"},{"issue":"4","key":"doi220066r63","doi-asserted-by":"publisher","first-page":"344","DOI":"10.7150\/ijms.5349","article-title":"Identification and characterization of Wnt signaling pathway in keloid pathogenesis.","volume":"10","author":"Igota","year":"2013","journal-title":"Int J Med Sci"},{"key":"doi220066r64","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbplus.2019.100016","article-title":"Cartilage-like composition of keloid scar extracellular matrix suggests fibroblast mis-differentiation in disease.","volume":"4","author":"Barallobre-Barreiro","year":"2019","journal-title":"Matrix Biol Plus"},{"issue":"1","key":"doi220066r65","doi-asserted-by":"publisher","first-page":"21364","DOI":"10.1038\/s41598-020-78206-4","article-title":"Canonical and noncanonical TGF-\u00df signaling regulate fibrous tissue differentiation in the axial skeleton.","volume":"10","author":"Clayton","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"doi220066r66","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1172\/JCI96186","article-title":"Aberrant TGF-\u00df activation in bone tendon insertion induces enthesopathy-like disease.","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest"},{"issue":"10","key":"doi220066r67","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3923","article-title":"Pruritus in keloid scars: mechanisms and treatments.","volume":"101","author":"Hawash","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"doi220066r68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/j.pain.0000000000001389","article-title":"The IASP classification of chronic pain for ICD-11: chronic secondary musculoskeletal pain.","volume":"160","author":"Perrot","year":"2019","journal-title":"Pain"},{"issue":"1","key":"doi220066r69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bjps.2004.04.024","article-title":"Keloid disease: clinical relevance of single versus multiple site scars.","volume":"58","author":"Bayat","year":"2005","journal-title":"Br J Plast Surg"},{"key":"doi220066r29","unstructured":"Gohel? D. Flextable: functions for tabular reporting. Accessed November 29, 2022. https:\/\/cran.r-project.org\/web\/packages\/flextable\/index.html"},{"key":"doi220066r32","unstructured":"Warwick? A. Ukbwranglr: exploring UKB data. Accessed November 29, 2022. https:\/\/github.com\/rmgpanw\/ukbwranglr"},{"key":"doi220066r33","unstructured":"Warwick? A. Codemapper: functions for mapping between clinical coding systems. Accessed November 29, 2022. https:\/\/github.com\/rmgpanw\/codemapper"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2800120\/jamadermatology_ung_2023_oi_220066_1675100213.56973.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:05:20Z","timestamp":1676459120000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2800120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.5607","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,1]]}}}